We're raising our price target on Eli Lilly as the obesity-drug boom rolls on

CNBC - Oct 29, 2026

The Lilly train keeps on rolling thanks to Mounjaro and Zepbound. And there's more growth to be had.

Read full article
More News

Subscribe Now!

About Us

The Journalist Report publishes timely news updates around the clock. We have a group of journalists around the globe to deliver the latest news around so that we can get our users connected.